The Austedo approval is notable for two reasons: One, it is the first deuterated drug (i.e., a drug containing the stable isotope — deuterium — in place of a hydrogen atom) to be approved by ...
The global deuterated drugs market, valued at US$ 334.0 million in 2023, presents a robust growth pattern. With a projected valuation of US$ 871.8 million by 2032 at a CAGR of 11.25%, the market is ...
“We are making rapid advancements in our two lead clinical programs – CYB003, our proprietary deuterated psilocin program in development for the adjunctive treatment of Major Depressive ...
With his colleague, Jin Xie, Zhu also designed deoxygenation approaches for synthesizing ketones from aromatic carboxylic acids and alkenes, and for preparing deuterated aldehydes from aromatic ...
Discover Sun Pharmaceutical's new patent for synthesizing D-serine-2-d, detailing innovative methods and versatile compounds for advanced pharmaceutical applications.
We have two assets in the clinic at the moment. Our CYB003 program, which is a deuterated psilocin, has completed Phase 2. We have some really spectacular Phase 2 results that I'd be happy to ...
Cybin has strengthened its clinical and R&D team with the recent addition of senior team members: Dr. Mirza Rahman, M.D., M.P.H., FACPM, Senior Vice President, Patient Safety & Pharmacovigilance. Dr.